Targeting MRP3 in Pancreatic Cancer In Vitro
Pancreatic cancer is currently one of the most aggressive and resistant cancers. The incidences rates of pancreatic cancer are comparatively low. However, the death rates of pancreatic cancer are within the top 10 of all cancers worldwide. The five-year survival rate is currently 5%, meaning that 95...
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Others |
| Published: |
Auckland University of Technology,
2020-06-16T00:33:28Z.
|
| Subjects: | |
| Online Access: | Get fulltext |